PDT Partners’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-11,131
| Closed | -$34K | – | 829 |
|
2024
Q4 | $34K | Hold |
11,131
| – | – | ﹤0.01% | 700 |
|
2024
Q3 | $28.4K | Hold |
11,131
| – | – | ﹤0.01% | 710 |
|
2024
Q2 | $36.3K | Buy |
+11,131
| New | +$36.3K | ﹤0.01% | 654 |
|
2023
Q3 | – | Sell |
-21,946
| Closed | -$77.5K | – | 655 |
|
2023
Q2 | $77.5K | Hold |
21,946
| – | – | 0.01% | 539 |
|
2023
Q1 | $67.8K | Buy |
21,946
+2,800
| +15% | +$8.65K | 0.01% | 546 |
|
2022
Q4 | $81K | Buy |
+19,146
| New | +$81K | 0.01% | 587 |
|
2022
Q2 | – | Sell |
-46,494
| Closed | -$134K | – | 1106 |
|
2022
Q1 | $134K | Sell |
46,494
-21,597
| -32% | -$62.2K | 0.01% | 848 |
|
2021
Q4 | $207K | Buy |
68,091
+1,363
| +2% | +$4.14K | 0.02% | 760 |
|
2021
Q3 | $468K | Buy |
66,728
+606
| +0.9% | +$4.25K | 0.03% | 494 |
|
2021
Q2 | $607K | Sell |
66,122
-5,733
| -8% | -$52.6K | 0.04% | 474 |
|
2021
Q1 | $698K | Sell |
71,855
-10,105
| -12% | -$98.2K | 0.05% | 442 |
|
2020
Q4 | $841K | Sell |
81,960
-46,358
| -36% | -$476K | 0.06% | 357 |
|
2020
Q3 | $1.3M | Sell |
128,318
-60,220
| -32% | -$608K | 0.09% | 267 |
|
2020
Q2 | $1.97M | Sell |
188,538
-15,700
| -8% | -$164K | 0.13% | 212 |
|
2020
Q1 | $1.72M | Buy |
204,238
+36,638
| +22% | +$309K | 0.14% | 169 |
|
2019
Q4 | $1.47M | Sell |
167,600
-82,809
| -33% | -$725K | 0.09% | 226 |
|
2019
Q3 | $2.7M | Buy |
250,409
+62,709
| +33% | +$675K | 0.16% | 167 |
|
2019
Q2 | $2.39M | Buy |
187,700
+65,600
| +54% | +$834K | 0.14% | 168 |
|
2019
Q1 | $4.74M | Sell |
122,100
-50
| -0% | -$1.94K | 0.27% | 121 |
|
2018
Q4 | $2.49M | Buy |
+122,150
| New | +$2.49M | 0.14% | 169 |
|
2015
Q3 | – | Sell |
-3,692
| Closed | -$431K | – | 1487 |
|
2015
Q2 | $431K | Buy |
+3,692
| New | +$431K | 0.01% | 1021 |
|
2013
Q4 | – | Sell |
-9,924
| Closed | -$533K | – | 1030 |
|
2013
Q3 | $533K | Buy |
9,924
+2,379
| +32% | +$128K | 0.01% | 1017 |
|
2013
Q2 | $335K | Buy |
+7,545
| New | +$335K | 0.01% | 1223 |
|